Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 39 Total
VERY - Vericity Inc - Stock Price Chart
TickerVERY [NASD]
CompanyVericity Inc
CountryUSA
IndustryInsurance - Life
Market Cap165.61MEPS (ttm)-0.83
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-27.42%
P/S0.97EPS next 5Y-
P/B1.43EPS Q/Q-
Dividend-Sales Q/Q4.57%
Insider Own84.98%Inst Own1.47%
Insider Trans0.00%Inst Trans0.45%
Short Float0.17%Earnings-
Analyst Recom-Target Price-
Avg Volume2.96K52W Range4.70 - 9.28
Vericity, Inc. provides life insurance services. It operates through the following segments: Agency, Insurance, and Corporate. The Agency Segment operates through Efinancial, which sells insurance products through its call center distribution platform and through its independent agents and other marketing organizations. The Insurance Segment operates through Fidelity Life, which engages in the principal business lines of Core Life, Non-Core Life, Closed Block, and annuities and assumed life. The Corporate Segment consists primarily of a small amount of capital required to be maintained for regulatory purposes, and also includes certain expenses considered to be corporate and not allocated to Agency or Insurance Segments. The company was founded in 2013 and is headquartered in Des Plaines, IL.
PNT - POINT Biopharma Global Inc - Stock Price Chart
TickerPNT [NASD, RUT]
CompanyPOINT Biopharma Global Inc
CountryUSA
IndustryBiotechnology
Market Cap1.31BEPS (ttm)0.87
P/E14.23EPS this Y-
Forward P/E-EPS next Y-16.93%
PEG-EPS past 5Y-
P/S5.43EPS next 5Y-
P/B2.92EPS Q/Q11.84%
Dividend-Sales Q/Q-
Insider Own18.65%Inst Own56.43%
Insider Trans0.00%Inst Trans24.86%
Short Float8.17%EarningsAug 14/b
Analyst Recom1.08Target Price16.90
Avg Volume537.47K52W Range5.59 - 11.13
POINT Biopharma Global, Inc. is a radiopharmaceutical company. It engages in the business of building a platform for the clinical development and commercialization of radioligands that fight cancer. The company was founded by Joe McCann and Neil E. Fleshner on April 15, 2020 and is headquartered in Indianapolis, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HOGUE GERALD L.DirectorMar 21Option Exercise6.9717,936125,01421,596Mar 23 08:09 PM
MCCANN JOE A.Chief Executive OfficerNov 29Buy6.642,16014,3423,616,313Nov 30 07:56 PM
Malik RajeshDirectorNov 28Buy6.663,70024,6423,700Nov 28 04:01 PM
HOGUE GERALD L.DirectorNov 25Buy6.823,66024,9433,660Nov 28 04:02 PM
Lubner David CharlesDirectorNov 23Buy6.853,60024,6603,600Nov 28 04:03 PM
ALXO - Alx Oncology Holdings Inc - Stock Price Chart
TickerALXO [NASD, RUT]
CompanyAlx Oncology Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap304.26MEPS (ttm)-3.19
P/E-EPS this Y-4.40%
Forward P/E-EPS next Y-5.58%
PEG-EPS past 5Y-58.82%
P/S-EPS next 5Y-
P/B1.43EPS Q/Q-3.29%
Dividend-Sales Q/Q-
Insider Own55.28%Inst Own44.42%
Insider Trans-0.06%Inst Trans1.24%
Short Float16.48%EarningsAug 10/a
Analyst Recom1.33Target Price27.83
Avg Volume160.07K52W Range3.94 - 13.64
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pinto ShellyVP, Finance and CAOJul 06Sale6.527,34547,88955,713Jul 07 04:09 PM
Pons JaumePresident & CEOJun 30Sale7.343,20823,547536,538Jul 05 05:07 PM
Randolph SophiaChief Medical OfficerJun 30Sale7.341,60511,781281,477Jul 05 05:09 PM
GARCIA PETER SChief Financial OfficerJun 30Sale7.348876,51154,738Jul 05 05:00 PM
Pinto ShellyVP, Finance and CAOJun 30Sale7.344663,42063,058Jul 05 05:05 PM
CNXA - Connexa Sports Technologies Inc - Stock Price Chart
TickerCNXA [NASD]
CompanyConnexa Sports Technologies Inc
CountryUSA
IndustryLeisure
Market Cap2.65MEPS (ttm)-107.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.21EPS next 5Y-
P/B-EPS Q/Q69.72%
Dividend-Sales Q/Q-51.19%
Insider Own17.63%Inst Own5.68%
Insider Trans0.00%Inst Trans-
Short Float4.33%Earnings-
Analyst Recom-Target Price-
Avg Volume320.97K52W Range2.52 - 32.00
Connexa Sports Technologies, Inc. engages in the design and development of portable ball launchers, and other practice equipment solutions for all ball sports. The company was founded by Joe Kalfa in 2017 and is headquartered in Windsor Mill, DE.
SPRC - SciSparc Ltd - Stock Price Chart
TickerSPRC [NASD]
CompanySciSparc Ltd
CountryIsrael
IndustryBiotechnology
Market Cap64.50MEPS (ttm)-1.33
P/E-EPS this Y-2371.07%
Forward P/E-EPS next Y-6.96%
PEG-EPS past 5Y-62.50%
P/S47.78EPS next 5Y-
P/B5.27EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own0.92%Inst Own0.05%
Insider Trans0.00%Inst Trans-
Short Float0.12%Earnings-
Analyst Recom1.00Target Price520.00
Avg Volume166.72K52W Range3.15 - 41.34
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.
DLA - Delta Apparel Inc. - Stock Price Chart
TickerDLA [AMEX]
CompanyDelta Apparel Inc.
CountryUSA
IndustryApparel Manufacturing
Market Cap56.21MEPS (ttm)-2.45
P/E-EPS this Y-
Forward P/E115.88EPS next Y-
PEG-EPS past 5Y16.06%
P/S0.13EPS next 5Y15.00%
P/B0.34EPS Q/Q-
Dividend-Sales Q/Q-16.20%
Insider Own14.73%Inst Own58.74%
Insider Trans0.58%Inst Trans-3.79%
Short Float1.80%EarningsAug 03/a
Analyst Recom5.00Target Price33.00
Avg Volume52.08K52W Range6.45 - 17.39
Delta Apparel, Inc. engages in the design, merchandise, and marketing of lifestyle branded active wear apparel and headwear. It operates through the Delta Group and Salt Life Group segments. The Delta Group segment consists of the business units DTG2Go, Delta Activewear, and Soffe, which are primarily focused on core activewear styles. The Salt Life Group segment includes lifestyle brands focused on a range of apparel garments, headwear, and related accessories to meet consumer preferences and fashion trends, along with Salt Life and Coast business units. The company was founded in 1999 and is headquartered in Duluth, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stillwell Jeffery NeilPresident, Salt Life GroupMay 19Buy9.473,00028,41059,157May 22 09:33 PM
Stillwell Jeffery NeilPresident, Salt Life GroupMay 18Buy9.903,00029,70056,157May 22 09:33 PM
HOOD GLENDA EDirectorDec 05Buy12.931,50019,39412,063Dec 07 04:11 PM
WHALEN DAVID GDirectorDec 02Buy12.904395,66319,750Dec 05 04:09 PM
Campbell James BradleyDirectorDec 01Buy13.252,00026,50024,750Dec 02 04:08 PM
LPTX - Leap Therapeutics Inc - Stock Price Chart
TickerLPTX [NASD]
CompanyLeap Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap39.63MEPS (ttm)-6.55
P/E-EPS this Y16.50%
Forward P/E-EPS next Y46.31%
PEG-EPS past 5Y31.98%
P/S-EPS next 5Y-2.49%
P/B0.47EPS Q/Q39.45%
Dividend-Sales Q/Q-
Insider Own8.13%Inst Own27.73%
Insider Trans0.00%Inst Trans-5.00%
Short Float2.92%EarningsAug 14/b
Analyst Recom1.40Target Price43.00
Avg Volume247.90K52W Range1.24 - 10.20
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.
SMLP - Summit Midstream Partners LP - Stock Price Chart
TickerSMLP [NYSE]
CompanySummit Midstream Partners LP
CountryUSA
IndustryOil & Gas Midstream
Market Cap162.45MEPS (ttm)-8.04
P/E-EPS this Y-
Forward P/E9.21EPS next Y95.40%
PEG-EPS past 5Y-
P/S0.42EPS next 5Y-
P/B0.25EPS Q/Q79.92%
Dividend-Sales Q/Q-1.18%
Insider Own4.07%Inst Own47.21%
Insider Trans-0.35%Inst Trans-2.69%
Short Float0.13%EarningsAug 09/a
Analyst Recom3.00Target Price25.00
Avg Volume10.29K52W Range13.00 - 21.49
Summit Midstream Partners LP engages in the development, ownership, and operation of midstream energy infrastructure assets that are located in unconventional resource basins, primarily shale formations. It operates through the following segments: Utica Shale, Ohio Gathering, Williston Basin, DJ Basin, Permian Basin, Piceance Basin, Barnett Shale, and Marcellus Shale. The company was founded by Steven J. Newby in May 2012 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Johnston James DavidSee remarks below.Jun 15Sale17.001,48725,27935,262Jun 16 10:16 AM
Johnston James DavidSee remarks below.Mar 15Sale17.00881,49621,078Mar 17 08:37 PM
Johnston James DavidSee remarks below.Mar 07Sale19.001,57529,92521,166Mar 09 07:24 AM
Johnston James DavidSee remarks below.Dec 15Sale17.851,57528,11422,741Dec 19 07:46 AM
Johnston James DavidSee remarks below.Oct 24Sale19.001,55729,58324,316Oct 26 07:14 AM
CURV - Torrid Holdings Inc - Stock Price Chart
TickerCURV [NYSE, RUT]
CompanyTorrid Holdings Inc
CountryUSA
IndustryApparel Retail
Market Cap237.28MEPS (ttm)0.21
P/E10.85EPS this Y-85.16%
Forward P/E11.67EPS next Y174.32%
PEG0.43EPS past 5Y-
P/S0.20EPS next 5Y25.00%
P/B-EPS Q/Q-70.89%
Dividend-Sales Q/Q-15.18%
Insider Own89.93%Inst Own4.08%
Insider Trans0.24%Inst Trans-1.88%
Short Float16.06%EarningsSep 06/a
Analyst Recom3.00Target Price2.35
Avg Volume253.07K52W Range1.21 - 5.19
Torrid Holdings, Inc. operates e-Commerce platform for apparel and intimates. It offers direct-to-consumer brand of womens plus-size apparel and intimates. The firm products include tops, denim, dresses, intimates, active wear, footwear and accessories. The company was founded in 2015 and is headquartered in City of Industry, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mizicko MarkChief Commercial OfficerSep 21Buy1.33225,000299,5202,321,987Sep 25 04:56 PM
Killion TheoDirectorDec 19Buy2.8210,00028,17437,429Dec 19 05:17 PM
FUSN - Fusion Pharmaceuticals Inc - Stock Price Chart
TickerFUSN [NASD]
CompanyFusion Pharmaceuticals Inc
CountryCanada
IndustryBiotechnology
Market Cap191.82MEPS (ttm)-1.93
P/E-EPS this Y16.06%
Forward P/E-EPS next Y9.09%
PEG-EPS past 5Y-118.51%
P/S518.43EPS next 5Y-
P/B0.94EPS Q/Q13.66%
Dividend-Sales Q/Q-94.04%
Insider Own30.55%Inst Own48.51%
Insider Trans0.00%Inst Trans-3.19%
Short Float0.27%EarningsAug 08/b
Analyst Recom1.08Target Price13.00
Avg Volume48.61K52W Range1.98 - 5.63
Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant in 2014 and is headquartered in Hamilton, Canada.
1234